| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |